Comprehensive Cancer Center

5841 South Maryland Avenue
Chicago, Illinois 60637

We've found

2 trials

at this facility

A Study of Parsaclisib in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Chicago, IL

Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

Chicago, IL

Use our guide to learn which trials are right for you!